NCT05197725

Face Masks to Reduce SARS-CoV-2 Infections (COVID-19) in Bangladesh

Name: Clinical Trial NCT05197725
Creator: Yale University
Keywords: Covid19, Face mask, device, clinical trial, Bangladesh

Face Masks to Reduce Symptomatic and Asymptomatic SARS-CoV-2 Infections in Bangladesh

Yale University·ClinicalTrials.gov·device·Device trialWithdrawn

View on ClinicalTrials.gov →

Study focus

Disease/Condition: Covid19
Drug/Device/Intervention: Face mask
Study type: Interventional
Intervention type: device

Sponsor & location

Primary sponsor: Yale University
Location: Dhaka, Bangladesh

Timeline & enrollment

Phase: N/A
Start date: Feb 04, 2023
End date: May 30, 2023
Enrollment: 0 participants

Primary outcome

Asymptomatic and asymptomatic SARS-CoV-2 infection

Summary

The primary goal of the village-level intervention is to assess whether mask-wearing reduces community-level asymptomatic and symptomatic SARS-CoV-2 infections, assessed via PCR testing. The study also examines if community-based activation through values or individual activation through information results in higher mask-wearing.

ICD-10 classifications

COVID-19, virus identifiedCOVID-19, virus not identifiedCoronavirus infection, unspecified siteRift Valley feverPlague

Data source

Registry: ClinicalTrials.gov
Trial ID: NCT05197725
Type: Device Trial

About this record

Access comprehensive clinical trial information for NCT05197725 through Pure Global AI's free database. This phase not specified trial is sponsored by Yale University and is currently Withdrawn. The study focuses on Covid19. Target enrollment is 0 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.